BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2025.
World J Gastrointest Surg. Sep 27, 2025; 17(9): 110347
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.110347
Table 1 Demographic characteristics of the study population, mean ± SD/n (%)
Parameters
HFE (n = 107)
CSP (n = 106)
EMR (n = 108)
P1 value
P2 value
P3 value
Age (years)57.90 ± 13.2056.80 ± 11.6157.29 ± 12.351.5512.2892.172
Gender2.8472.6582.505
Male57 (53.27)56 (53.27)56 (51.85)
Female50 (46.73)50 (46.73)52 (48.15)
Smoking22 (20.56)22 (20.56)22 (20.37)2.9162.8352.916
Drinking35 (79.44)38 (32.71)38 (35.18)1.8872.7572.106
Course of disease, months14.24 ± 2.4514.31 ± 2.2514.08 ± 2.922.5171.5571.989
Hypertension20 (18.69)21 (19.81)22 (20.37)2.5082.7572.268
Diabetes11 (10.28)10 (9.43)13 (12.03)2.5081.6172.049
Hyperlipidemia20 (18.69)22 (20.75)23 (21.29)2.1152.7691.899
Coronary heart disease8 (7.48)6 (5.89)8 (7.15)1.7791.8152.955
Indication2.7962.8322.904
Screening33 (30.84)36 (33.96)35 (32.63)
Follow up19 (17.76)16 (15.09)21 (19.44)
For polypectomy22 (20.56)22 (20.75)22 (19.45)
Positive FOBT6 (5.61)8 (7.55)7 (6.48)
Symptoms27 (25.23)24 (22.64)23 (21.29)
Bowel preparation2.2352.1993.000
BBPS < 65 (4.67)6 (5.66)5 (4.62)
BBPS ≥ 6102 (95.33)100 (94.34)103 (95.38)


Write to the Help Desk